These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27812793)

  • 1. UK Iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches.
    Ritchie DL; Barria MA; Peden AH; Yull HM; Kirkpatrick J; Adlard P; Ironside JW; Head MW
    Acta Neuropathol; 2017 Apr; 133(4):579-595. PubMed ID: 27812793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients.
    Douet JY; Huor A; Cassard H; Lugan S; Aron N; Mesic C; Vilette D; Barrio T; Streichenberger N; Perret-Liaudet A; Delisle MB; Péran P; Deslys JP; Comoy E; Vilotte JL; Goudarzi K; Béringue V; Barria MA; Ritchie DL; Ironside JW; Andréoletti O
    Acta Neuropathol Commun; 2021 Aug; 9(1):145. PubMed ID: 34454616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid-β accumulation in the CNS in human growth hormone recipients in the UK.
    Ritchie DL; Adlard P; Peden AH; Lowrie S; Le Grice M; Burns K; Jackson RJ; Yull H; Keogh MJ; Wei W; Chinnery PF; Head MW; Ironside JW
    Acta Neuropathol; 2017 Aug; 134(2):221-240. PubMed ID: 28349199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years.
    Rudge P; Jaunmuktane Z; Adlard P; Bjurstrom N; Caine D; Lowe J; Norsworthy P; Hummerich H; Druyeh R; Wadsworth JD; Brandner S; Hyare H; Mead S; Collinge J
    Brain; 2015 Nov; 138(Pt 11):3386-99. PubMed ID: 26268531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iatrogenic Creutzfeldt-Jakob disease.
    Kobayashi A; Kitamoto T; Mizusawa H
    Handb Clin Neurol; 2018; 153():207-218. PubMed ID: 29887137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease.
    Llorens F; Villar-Piqué A; Hermann P; Schmitz M; Calero O; Stehmann C; Sarros S; Moda F; Ferrer I; Poleggi A; Pocchiari M; Catania M; Klotz S; O'Regan C; Brett F; Heffernan J; Ladogana A; Collins SJ; Calero M; Kovacs GG; Zerr I
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human prion diseases: surgical lessons learned from iatrogenic prion transmission.
    Bonda DJ; Manjila S; Mehndiratta P; Khan F; Miller BR; Onwuzulike K; Puoti G; Cohen ML; Schonberger LB; Cali I
    Neurosurg Focus; 2016 Jul; 41(1):E10. PubMed ID: 27364252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropathological and biochemical criteria to identify acquired Creutzfeldt-Jakob disease among presumed sporadic cases.
    Kobayashi A; Parchi P; Yamada M; Mohri S; Kitamoto T
    Neuropathology; 2016 Jun; 36(3):305-10. PubMed ID: 26669818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic Creutzfeldt-Jakob disease with Amyloid-β pathology: an international study.
    Cali I; Cohen ML; Haik S; Parchi P; Giaccone G; Collins SJ; Kofskey D; Wang H; McLean CA; Brandel JP; Privat N; Sazdovitch V; Duyckaerts C; Kitamoto T; Belay ED; Maddox RA; Tagliavini F; Pocchiari M; Leschek E; Appleby BS; Safar JG; Schonberger LB; Gambetti P
    Acta Neuropathol Commun; 2018 Jan; 6(1):5. PubMed ID: 29310723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion Strain Characterization of a Novel Subtype of Creutzfeldt-Jakob Disease.
    Galeno R; Di Bari MA; Nonno R; Cardone F; Sbriccoli M; Graziano S; Ingrosso L; Fiorini M; Valanzano A; Pasini G; Poleggi A; Vinci R; Ladogana A; Puopolo M; Monaco S; Agrimi U; Zanusso G; Pocchiari M
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28298604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?
    Kobayashi A; Parchi P; Yamada M; Brown P; Saverioni D; Matsuura Y; Takeuchi A; Mohri S; Kitamoto T
    J Virol; 2015 Apr; 89(7):3939-46. PubMed ID: 25609817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients.
    Moore RA; Head MW; Ironside JW; Ritchie DL; Zanusso G; Choi YP; Priola SA
    PLoS Pathog; 2016 Feb; 12(2):e1005416. PubMed ID: 26840342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The French surveillance network of Creutzfeldt-Jakob disease. Epidemiological data in France and worldwide.
    Brandel JP; Peckeu L; Haïk S
    Transfus Clin Biol; 2013 Sep; 20(4):395-7. PubMed ID: 23587616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.
    Parchi P; Cescatti M; Notari S; Schulz-Schaeffer WJ; Capellari S; Giese A; Zou WQ; Kretzschmar H; Ghetti B; Brown P
    Brain; 2010 Oct; 133(10):3030-42. PubMed ID: 20823086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar genetic susceptibility in iatrogenic and sporadic Creutzfeldt-Jakob disease.
    Deslys JP; Marcé D; Dormont D
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():23-7. PubMed ID: 8113733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropathology of iatrogenic Creutzfeldt-Jakob disease and immunoassay of French cadaver-sourced growth hormone batches suggest possible transmission of tauopathy and long incubation periods for the transmission of Abeta pathology.
    Duyckaerts C; Sazdovitch V; Ando K; Seilhean D; Privat N; Yilmaz Z; Peckeu L; Amar E; Comoy E; Maceski A; Lehmann S; Brion JP; Brandel JP; Haïk S
    Acta Neuropathol; 2018 Feb; 135(2):201-212. PubMed ID: 29209767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002.
    Head MW; Bunn TJ; Bishop MT; McLoughlin V; Lowrie S; McKimmie CS; Williams MC; McCardle L; MacKenzie J; Knight R; Will RG; Ironside JW
    Ann Neurol; 2004 Jun; 55(6):851-9. PubMed ID: 15174020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone.
    Purro SA; Farrow MA; Linehan J; Nazari T; Thomas DX; Chen Z; Mengel D; Saito T; Saido T; Rudge P; Brandner S; Walsh DM; Collinge J
    Nature; 2018 Dec; 564(7736):415-419. PubMed ID: 30546139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between Bioassay and Protein Misfolding Cyclic Amplification for Variant Creutzfeldt-Jakob Disease Decontamination Studies.
    Bélondrade M; Jas-Duval C; Nicot S; Bruyère-Ostells L; Mayran C; Herzog L; Reine F; Torres JM; Fournier-Wirth C; Béringue V; Lehmann S; Bougard D
    mSphere; 2020 Jan; 5(1):. PubMed ID: 31996421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Abundance of apoE and Aβ1-42 Associated with Abnormal Prion Protein Differs between Creutzfeldt-Jakob Disease Subtypes.
    Moore RA; Choi YP; Head MW; Ironside JW; Faris R; Ritchie DL; Zanusso G; Priola SA
    J Proteome Res; 2016 Dec; 15(12):4518-4531. PubMed ID: 27597180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.